CogliatiA.A., VellutiniR., NardiniA., UroviS., HamdanM., LandoniG., GuelfiP.. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study.J Cardiothorac Vasc Anesth2007; 21: 847–50.
3.
RoasioA., LobreglioR., SantinA., LandoniG., VerdecchiaC.. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.J Cardiothorac Vasc Anesth2008; 22: 23–6.
4.
LandoniG., Biondi-ZoccaiG.G., TumlinJ.A., BoveT., De LucaM., CalabròM.G., RanucciM., ZangrilloA.. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.Am J Kidney Dis2007; 49: 56–68.
5.
LandoniG., Biondi-ZoccaiG.G., MarinoG., BoveT., FochiO., MajG., CalabròM.G., SheibanI., TumlinJ.A., RanucciM., ZangrilloA.. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.J Cardiothorac Vasc Anesth2008; 22: 27–33.
